Protagonist Therapeutics Depreciation & Amortization 2011-2026 | PTGX

Annual Depreciation & Amortization Protagonist Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
1.28 M	826 K	977 K	1.03 M	813 K	948 K	732 K	527 K	406 K	317 K	247 K	258 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.28 M	247 K	697 K

Quarterly Depreciation & Amortization Protagonist Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	239 K	-	-	-	236 K	-	-	-	248 K	-	778 K	-	249 K	-	578 K	-	180 K	-	601 K	419 K	217 K	-	501 K	306 K	130 K	-	399 K	248 K	78 K	-	289 K	181 K	88 K	-	242 K	159 K	73 K	-	160 K	111 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
778 K	73 K	280 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.34	-3.6 %	$ 357 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
DBV Technologies S.A. DBVT	2.99 M	$ 20.13	-1.13 %	$ 2.81 B	France
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.57	-3.57 %	$ 16.1 M	USA
Equillium EQ	116 K	$ 2.04	1.24 %	$ 117 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Fate Therapeutics FATE	12.9 M	$ 1.13	-5.04 %	$ 134 M	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Forte Biosciences FBRX	64 K	$ 26.57	0.49 %	$ 344 M	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Foghorn Therapeutics FHTX	3.33 M	$ 4.74	-2.87 %	$ 299 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Amicus Therapeutics FOLD	7.46 M	$ 14.46	0.03 %	$ 4.46 B	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Fulcrum Therapeutics FULC	1.39 M	$ 7.55	-3.58 %	$ 478 K	USA
Galectin Therapeutics GALT	1 K	$ 2.25	-12.3 %	$ 144 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Gilead Sciences GILD	370 M	$ 138.19	-1.38 %	$ 172 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.61	-3.59 %	$ 189 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Galmed Pharmaceuticals Ltd. GLMD	42 K	$ 0.54	4.26 %	$ 503 K	Israel
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 314.44	-4.81 %	$ 41.2 B	USA
Gossamer Bio GOSS	24 K	$ 0.32	-7.11 %	$ 73.1 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
GT Biopharma GTBP	4 K	$ 0.42	-6.49 %	$ 2.32 M	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Halozyme Therapeutics HALO	11.4 M	$ 63.51	0.68 %	$ 7.61 B	USA